NCT03394989View on ClinicalTrials.gov

BE Study of Fluticasone Propionate/Salmeterol Inhalation Powder in Asthma Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

1,366

Participants

Timeline

Start Date

October 17, 2018

Primary Completion Date

December 3, 2019

Study Completion Date

March 31, 2020

Conditions
Bronchial Asthma
Interventions
DRUG

Fluticasone propionate/salmeterol 100/50 µg

Test Arm: Dry powder inhaler

OTHER

Placebo

Placebo

DRUG

Advair Diskus 100/50 Dry Powder Inhaler, 60 ACTUAT

Comparator Arm: Dry powder inhaler

Trial Locations (1)

32807

Combined Research Orlando, Orlando

All Listed Sponsors
lead

Cipla Ltd.

INDUSTRY

NCT03394989 - BE Study of Fluticasone Propionate/Salmeterol Inhalation Powder in Asthma Patients | Biotech Hunter | Biotech Hunter